Is GoodRx Holdings, Inc. overvalued or undervalued?

As of 17 October 2025, GoodRx Holdings, Inc. has moved from an attractive to a fair valuation grade. Based on the current metrics, the company appears to be fairly valued. The P/E ratio stands at 38, which is significantly higher than the peer average of approximately 31.76 for GoodRx, while the EV to EBITDA ratio of 9.64 is more favorable compared to the industry average. Additionally, the Price to Book Value is 2.23, indicating a reasonable valuation relative to its book value.
In comparison to its peers, GoodRx Holdings, Inc. has a more favorable EV to EBITDA ratio than PropertyGuru Group Ltd., which has a ratio of 144.58, and significantly better than other risky peers like ZipRecruiter, Inc. and Cardlytics, Inc. Despite the lack of recent return data, the absence of a notable return comparison against the S&P 500 suggests that the stock's performance may not have been particularly strong, which aligns with its current fair valuation status.